0001123292-19-000749.txt : 20190513 0001123292-19-000749.hdr.sgml : 20190513 20190513193215 ACCESSION NUMBER: 0001123292-19-000749 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190513 FILED AS OF DATE: 20190513 DATE AS OF CHANGE: 20190513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CANAAN X L.P. CENTRAL INDEX KEY: 0001619859 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38905 FILM NUMBER: 19820098 BUSINESS ADDRESS: STREET 1: 285 RIVERSIDE AVE. STREET 2: SUITE 250 CITY: WESTPORT STATE: CT ZIP: 06880 BUSINESS PHONE: 203-855-0400 MAIL ADDRESS: STREET 1: 285 RIVERSIDE AVE. STREET 2: SUITE 250 CITY: WESTPORT STATE: CT ZIP: 06880 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Canaan Partners X LLC CENTRAL INDEX KEY: 0001673228 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38905 FILM NUMBER: 19820099 BUSINESS ADDRESS: STREET 1: 2765 SAND HILL ROAD CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 6508548092 MAIL ADDRESS: STREET 1: 2765 SAND HILL ROAD CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NextCure, Inc. CENTRAL INDEX KEY: 0001661059 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 475231247 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9000 VIRGINIA MANOR ROAD, SUITE 200 CITY: BELTSVILLE STATE: MD ZIP: 20705 BUSINESS PHONE: 240-399-4900 MAIL ADDRESS: STREET 1: 9000 VIRGINIA MANOR ROAD, SUITE 200 CITY: BELTSVILLE STATE: MD ZIP: 20705 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2019-05-13 1 0001661059 NextCure, Inc. NXTC 0001619859 CANAAN X L.P. C/O CANAAN PARTNERS 285 RIVERSIDE AVENUE, SUITE 250 WESTPORT CT 06880 0 0 1 0 0001673228 Canaan Partners X LLC C/O CANAAN PARTNERS 285 RIVERSIDE AVENUE, SUITE 250 WESTPORT CT 06880 0 0 1 0 Common Stock 2019-05-13 4 C 0 445866 A 445866 D Common Stock 2019-05-13 4 C 0 743110 A 1188976 D Common Stock 2019-05-13 4 C 0 729599 A 1918575 D Common Stock 2019-05-13 4 C 0 285867 A 2204442 D Common Stock 2019-05-13 4 P 0 50000 15.00 A 2254442 D Series A-1 Preferred Stock 2019-05-13 4 C 0 3582000 D Common Stock 445866 0 D Series A-2 Preferred Stock 2019-05-13 4 C 0 5970000 D Common Stock 743110 0 D Series A-3 Preferred Stock 2019-05-13 4 C 0 5861455 D Common Stock 729599 0 D Series B-1 Preferred Stock 2019-05-13 4 C 0 2296605 D Common Stock 285867 0 D The reported securities automatically converted into shares of Common Stock on a 1-for-8.0338 basis upon the closing of the Issuer's initial public offering and had no expiration date. The shares are held directly by Canaan X L.P. (the "Canaan Fund"). The sole general partner of the Canaan Fund is Canaan Partners X LLC ("Canaan X"), and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. Investment and voting decisions with respect to the shares held by the Canaan Fund are made by the managers of Canaan X, collectively. Canaan X disclaims Section 16 beneficial ownership of the securities held by the Canaan Fund, except to the extent of its pecuniary interest therein, if any. Exhibit 24 - Power of Attorney (incorporated herein by reference to the Power of Attorney filed as Exhibit 24 to the Form 3 filed by the Reporting Persons on May 8, 2019) Canaan X L.P., By: Canaan Partners X LLC, its general partner, By: /s/ Janine MacDonald, Attorney-in-Fact 2019-05-13 Canaan Partners X LLC, By: /s/ Janine MacDonald, Attorney-in-Fact 2019-05-13